Last reviewed · How we verify

NCT04791436

Oral and Olfactory Complications of Recovered COVID-19 Patients

Recruiting now Last updated 13 May 2024
What this trial tests

trial testing Gustatory and olfactory function test in Oral Complication in 402 participants. Currently enrolling.

Timeline
1 May 2021
Primary endpoint
30 January 2025
28 May 2025

Quick facts

Lead sponsorUniversity of Giessen
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment402
Start date1 May 2021
Primary completion30 January 2025
Estimated completion28 May 2025
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University of Giessen

Who can join

18 and older, any sex, with Oral Complication or Dysgeusia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This cohort study aims to investigate the long-standing chemosensory disorders and oral manifestation after recovery of the COVID-19 illness. A correlation between the long-standing symptoms and the COVID-19 severity grade will be very important to understand and clarify the aetiology of these symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Oral Complication

Currently open trials in the same condition.

Other University of Giessen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04791436.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing